Stryker Corporation $SYK Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. reduced its stake in Stryker Corporation (NYSE:SYK) by 81.3% in the fourth quarter, HoldingsChannel reports. The fund owned 10,690 shares of the medical technology company’s stock after selling 46,461 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Stryker were worth $3,757,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Blue Water Asset Management acquired a new stake in shares of Stryker in the 4th quarter worth approximately $955,000. Thrivent Financial for Lutherans lifted its stake in shares of Stryker by 22.1% in the 4th quarter. Thrivent Financial for Lutherans now owns 119,191 shares of the medical technology company’s stock worth $41,905,000 after acquiring an additional 21,548 shares during the period. Bank Julius Baer & Co. Ltd Zurich lifted its stake in shares of Stryker by 4.5% in the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 807,532 shares of the medical technology company’s stock worth $284,145,000 after acquiring an additional 34,765 shares during the period. Western Wealth Management LLC lifted its stake in shares of Stryker by 7.6% in the 4th quarter. Western Wealth Management LLC now owns 6,378 shares of the medical technology company’s stock worth $2,242,000 after acquiring an additional 453 shares during the period. Finally, TrueWealth Financial Partners acquired a new stake in shares of Stryker in the 4th quarter worth approximately $227,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Stryker

In related news, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president directly owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is owned by insiders.

Stryker Stock Down 0.0%

NYSE SYK opened at $316.39 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The company’s 50 day simple moving average is $325.22 and its 200 day simple moving average is $349.76. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $404.87. The company has a market capitalization of $121.29 billion, a P/E ratio of 36.62, a PEG ratio of 1.99 and a beta of 0.80.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the previous year, the firm earned $2.84 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is presently 40.74%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Sanford C. Bernstein set a $410.00 price target on shares of Stryker in a research note on Friday, May 1st. TD Cowen lowered shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target for the company. in a research note on Monday, January 26th. Piper Sandler reaffirmed an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. Citigroup reduced their price target on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Finally, Truist Financial reaffirmed a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $395.48.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.